{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:14:41Z","timestamp":1791220481673,"version":"4.1.0"},"reference-count":43,"publisher":"Impact Journals, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2023,5,31]]},"DOI":"10.18632\/aging.204748","type":"journal-article","created":{"date-parts":[[2023,5,25]],"date-time":"2023-05-25T00:15:50Z","timestamp":1684973750000},"page":"4444-4464","source":"Crossref","is-referenced-by-count":3,"title":["Development and validation of a novel T cell proliferation-related prognostic model for predicting survival and immunotherapy benefits in melanoma"],"prefix":"10.18632","volume":"15","author":[{"given":"Jiajie","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"},{"name":"Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, Anhui 230022, China"},{"name":"Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiyue","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"},{"name":"Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, Anhui 230022, China"},{"name":"Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shixin","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"},{"name":"Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, Anhui 230022, China"},{"name":"Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"},{"name":"Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, Anhui 230022, China"},{"name":"Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Gui","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"},{"name":"Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, Anhui 230022, China"},{"name":"Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuling","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"},{"name":"Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, Anhui 230022, China"},{"name":"Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinwei","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoxue","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"},{"name":"Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, Anhui 230022, China"},{"name":"Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Metabolic Disease Research Center, School of Basic Medicine, Anhui Medical University, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kechao","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Molecular Biology, Metabolic Disease Research Center, School of Basic Medicine, Anhui Medical University, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huabing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Affiliated Chuzhou Hospital of Anhui Medical University, The First People\u2019s Hospital of Chuzhou, Chuzhou, Anhui 230022, China"},{"name":"Department of Biochemistry and Molecular Biology, Metabolic Disease Research Center, School of Basic Medicine, Anhui Medical University, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxiu","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230022, China"},{"name":"Key Laboratory of Dermatology, Anhui Medical University, Ministry of Education, Hefei, Anhui 230022, China"},{"name":"Inflammation and Immune-Mediated Diseases Laboratory of Anhui Province, Hefei, Anhui 230022, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.semcancer.2019.08.002","article-title":"Unraveling the crosstalk between melanoma and immune cells in the tumor microenvironment.","volume":"5","author":"Manuel","year":"2019","journal-title":"Semin Cancer Biol"},{"key":"2","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.","volume":"13","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.3389\/fgene.2012.00330","article-title":"Genetics of melanoma.","volume":"3","author":"Chen","year":"2013","journal-title":"Front Genet"},{"key":"4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/archsurg.142.9.885","article-title":"Excision margins for primary cutaneous melanoma: updated pooled analysis of randomized controlled trials.","volume":"14","author":"Bataille","year":"2007","journal-title":"Arch Surg"},{"key":"5","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1056\/NEJMoa1503093","article-title":"Pembrolizumab versus Ipilimumab in Advanced Melanoma.","volume":"37","author":"Neyns","year":"2015","journal-title":"N Engl J Med"},{"key":"6","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa1504030","article-title":"Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma.","volume":"37","author":"Wagstaff","year":"2015","journal-title":"N Engl J Med"},{"key":"7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation.","volume":"37","author":"Lebb\u00e9","year":"2015","journal-title":"N Engl J Med"},{"key":"8","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice.","volume":"2","author":"Lenardo","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"9","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies.","volume":"1","author":"Bruni","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10","doi-asserted-by":"publisher","first-page":"e0004","DOI":"10.5041\/RMMJ.10179","article-title":"Adoptive T cell immunotherapy for cancer.","volume":"6","author":"Schneck","year":"2015","journal-title":"Rambam Maimonides Med J"},{"key":"11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1111\/j.1600-065X.2008.00662.x","article-title":"Control of peripheral T-cell tolerance and autoimmunity via the CTLA-4 and PD-1 pathways.","volume":"22","author":"Bluestone","year":"2008","journal-title":"Immunol Rev"},{"key":"12","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nrclinonc.2017.43","article-title":"Targeted agents and immunotherapies: optimizing outcomes in melanoma.","volume":"1","author":"Long","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"key":"13","doi-asserted-by":"publisher","first-page":"178","DOI":"10.3389\/fonc.2018.00178","article-title":"Melanoma Immunotherapy: Next-Generation Biomarkers.","volume":"8","author":"Cheng","year":"2018","journal-title":"Front Oncol"},{"key":"14","doi-asserted-by":"publisher","first-page":"106132","DOI":"10.18632\/oncotarget.22190","article-title":"Immune system and melanoma biology: a balance between immunosurveillance and immune escape.","volume":"8","author":"Silvestris","year":"2017","journal-title":"Oncotarget"},{"key":"15","doi-asserted-by":"publisher","first-page":"384","DOI":"10.21037\/atm.2017.09.09","article-title":"New trends in antitumor vaccines in melanoma.","volume":"5","author":"Berraondo","year":"2017","journal-title":"Ann Transl Med"},{"key":"16","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/exd.13792","article-title":"CAR-T cell therapy in melanoma: A future success story?","volume":"2","author":"Uslu","year":"2018","journal-title":"Exp Dermatol"},{"key":"17","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s40610-017-0073-7","article-title":"Tumor microenvironment heterogeneity: challenges and opportunities.","volume":"3","author":"Kelber","year":"2017","journal-title":"Curr Mol Biol Rep"},{"key":"18","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1586\/14737140.2015.1059279","article-title":"The importance of the tumor microenvironment in the therapeutic management of cancer.","volume":"1","author":"Quatresooz","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"key":"19","doi-asserted-by":"publisher","first-page":"2978","DOI":"10.1200\/JCO.2018.79.3398","article-title":"Tumor Mutation Burden: Is It Ready for the Clinic?","volume":"3","author":"Goto","year":"2018","journal-title":"J Clin Oncol"},{"key":"20","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/s41586-022-04494-7","article-title":"A genome-scale screen for synthetic drivers of T cell proliferation.","volume":"60","author":"Sanjana","year":"2022","journal-title":"Nature"},{"key":"21","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1126\/science.1203486","article-title":"Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion.","volume":"33","author":"Smyth","year":"2011","journal-title":"Science"},{"key":"22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response.","volume":"1","author":"Rosenberg","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"23","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A human memory T cell subset with stem cell-like properties.","volume":"1","author":"Price","year":"2011","journal-title":"Nat Med"},{"key":"24","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/s41577-021-00539-6","article-title":"Cellular networks controlling T cell persistence in adoptive cell therapy.","volume":"2","author":"Darcy","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"25","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/2159-8290.CD-20-1808","article-title":"Therapeutic Targeting of the Tumor Microenvironment.","volume":"1","author":"Joyce","year":"2021","journal-title":"Cancer Discov"},{"key":"26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1038\/s41568-021-00347-z","article-title":"Systemic immunity in cancer.","volume":"2","author":"Spitzer","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"27","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41392-021-00827-6","article-title":"Signal pathways of melanoma and targeted therapy.","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"28","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1093\/annonc\/mdz011","article-title":"Five-year survival outcomes for patients with advanced melanoma treated with pembrolizumab in KEYNOTE-001.","volume":"3","author":"Patnaik","year":"2019","journal-title":"Ann Oncol"},{"key":"29","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1056\/NEJMoa1904059","article-title":"Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma.","volume":"38","author":"Haanen","year":"2019","journal-title":"N Engl J Med"},{"key":"30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.soc.2010.09.007","article-title":"Staging and prognosis of cutaneous melanoma.","volume":"2","author":"Gershenwald","year":"2011","journal-title":"Surg Oncol Clin N Am"},{"key":"31","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma.","volume":"39","author":"Long","year":"2021","journal-title":"Lancet"},{"key":"32","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1172\/JCI80008","article-title":"Tumor neoantigens: building a framework for personalized cancer immunotherapy.","volume":"12","author":"Schreiber","year":"2015","journal-title":"J Clin Invest"},{"key":"33","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1158\/2159-8290.CD-18-0367","article-title":"Fundamental Mechanisms of Immune Checkpoint Blockade Therapy.","volume":"8","author":"Allison","year":"2018","journal-title":"Cancer Discov"},{"key":"34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/annonc\/mdy495","article-title":"Development of tumor mutation burden as an immunotherapy biomarker: utility for the oncology clinic.","volume":"3","author":"Peters","year":"2019","journal-title":"Ann Oncol"},{"key":"35","doi-asserted-by":"publisher","first-page":"eaar3593","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy.","volume":"36","author":"Joe","year":"2018","journal-title":"Science"},{"key":"36","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12916-015-0278-7","article-title":"New horizons in tumor microenvironment biology: challenges and opportunities.","volume":"1","author":"Sun","year":"2015","journal-title":"BMC Med"},{"key":"37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment.","volume":"2","author":"Coussens","year":"2012","journal-title":"Cancer Cell"},{"key":"38","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation.","volume":"45","author":"Balkwill","year":"2008","journal-title":"Nature"},{"key":"39","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S1470-2045(09)70036-1","article-title":"Melanoma of the small intestine.","volume":"1","author":"Krivokapic","year":"2009","journal-title":"Lancet Oncol"},{"key":"40","doi-asserted-by":"publisher","first-page":"15403","DOI":"10.1021\/acsnano.0c06000","article-title":"Microenvironment-Triggered Degradable Hydrogel for Imaging Diagnosis and Combined Treatment of Intraocular Choroidal Melanoma.","volume":"1","author":"Wang","year":"2020","journal-title":"ACS Nano"},{"key":"41","doi-asserted-by":"publisher","first-page":"11616","DOI":"10.1002\/jcb.28441","article-title":"Prognostic genes of hepatocellular carcinoma based on gene coexpression network analysis.","volume":"12","author":"Lin","year":"2019","journal-title":"J Cell Biochem"},{"key":"42","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s12967-015-0693-8","article-title":"Tumor size, stage and grade alterations of urinary peptidome in RCC.","volume":"1","author":"Magni","year":"2015","journal-title":"J Transl Med"},{"key":"43","doi-asserted-by":"publisher","first-page":"847","DOI":"10.7150\/jca.66177","article-title":"Rutaecarpine suppresses the proliferation and metastasis of colon cancer cells by regulating the STAT3 signaling.","volume":"1","author":"Chen","year":"2022","journal-title":"J Cancer"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204748","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T21:17:39Z","timestamp":1685999859000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.204748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":43,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,5,31]]}},"alternative-id":["204748","37227816"],"URL":"https:\/\/doi.org\/10.18632\/aging.204748","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]}}}